Inhaled ciclesonide given nod by FDA
Alvesco approved for asthma
Prodrug ciclesonide, activated by intracellular esterases following oral inhalation, has been approved by the FDA as an inhalation aerosol for use as a prophylactic therapy in adults and adolescents aged 12 years and older with asthma. The drug is called a new generation of corticosteroid by manufacturer
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Related Content
